Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

European Research Council grant · Running

GROW-REG Identifying physeal cell surface markers for paediatric growth modulation

Coordinator
University College Dublin, National University of Ireland, Dublin, Ireland
Runs
1 September 2026 to 29 February 2028
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101334807

What the project is doing

In the project's own words, from its summary on CORDIS.

Disorders of skeletal growth in children represent a significant clinical challenge affecting stature, limb alignment and function. Longitudinal bone growth is driven by the physis (growth plate), a specialised cartilaginous tissue that integrates endocrine, metabolic and biomechanical signals to regulate bone elongation. Despite its central role in skeletal development, there is currently no strategy to selectively target the physis for therapeutic intervention.

Existing treatments rely on systemic hormone therapy or invasive surgery, both of which lack anatomical specificity and can cause significant side effects or morbidity. GROW-REG aims to establish the first molecular targeting platform for the physis by identifying cell surface markers that are enriched in physeal chondrocytes relative to articular cartilage and remain robust across postnatal development. These proteins represent potential molecular entry points for selective delivery of therapeutics directly to growth plate signalling pathways.

The project builds on discoveries from the ERC-funded ReZone project, which revealed major transcriptomic differences between articular and physeal cartilage. The research will generate the first systematic map of the physeal chondrocyte “surfaceome”. Candidate markers will be prioritised based on enrichment in physis over articular cartilage, confirmed cell-surface localisation, reproducibility across developmental stages, and suitability for therapeutic targeting.

GROW-REG will create the foundation for a targeted delivery platform capable of modulating growth plate activity with high anatomical precision. Our approach has the potential to enable new treatments for a broad range of paediatric growth disorders, reduce reliance on invasive surgery, and improve the safety and specificity of existing biologic therapies.

Topics

Who is involved

OrganisationCityCountryRole
University College Dublin, National University of Ireland, DublinDublinIrelandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI